Cyclophosphamide

adeno-associated virus integration site 1 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30168260 Vasculitis research: Current trends and future perspectives. 2019 Jan 1
2 31277751 Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide? 2019 Aug 2
3 30526892 The complications of vasculitis and its treatment. 2018 Feb 1
4 28956128 Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes. 2017 Nov 1
5 27023359 Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides. 2016 Apr 3
6 27356598 Treatment of renal ANCA-associated vasculitides. 2016 Jun 28 1
7 28936387 Clinical Trials in Vasculitis. 2016 1
8 26021670 Update on the treatment of ANCA associated vasculitis. 2015 Jun 1
9 26031284 [Treatment strategies for ANCA-associated vasculitides]. 2015 Jun 1
10 26149512 Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients? 2015 1
11 24688606 Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis. 2014 Apr 2
12 23641277 Strategy of Infection Control in Immunosuppressive Therapy for ANCA-Associated Vasculitis. 2013 1